Respiratory – Page 3

Clinical Remission in Patients with Severe Eosinophilic Asthma Treated with Benralizumab Who Were Randomised to Reduce Their Inhaled Corticosteroid/ Formoterol Dose: SHAMAL Post-hoc Analysis

This post-hoc analysis was presented by Prof. Gilles Devouassoux et al from PUPH Pneumologie, chef de service, Hospices Civils de Lyon, France at the ERS

Impact on Quality of Life in Greek Asthmatic Patients Receiving Budesonide/Formoterol FDC as Maintenance Treatment, with or Without Additional Reliever Treatment Results from the NOTOS Study

This Retrospective cohort study was presented by Dr. Maria Bertoli et al from the Elpen Pharmaceuticals Co. Inc. Medical, Athens, Greece at the ERS Congress

Minimal Clinically Important Difference for Impulse Oscillometry in Adults with Asthma (Oral Presentation)

This poster was presented by Dr Mustafa Abdo (Germany) on Sunday September 10th 2023 at the European Respiratory Society (ERS) International Congress held at Milan,

Comparison of Forced Oscillation Technique(FOT) with Spirometry Measures in AcuteAsthma (Oral Presentation)

This poster was presented by Dr P. Andrade Almeida (Nottingham, United Kingdom), on Sunday September 10th 2023 at the European Respiratory Society (ERS) International Congress

SHAMAL: Reduction of Maintenance Inhaled Corticosteroids in Patients with Severe Eosinophilic Asthma Treated with Benralizumab: A Randomised Phase 4 Study (Clinical Trial)

This late breaking abstract was presented by Dr David Jackson (UK) on Sunday September 10th 2023 at the European Respiratory Society (ERS) International Congress held

The Immune System and Obesity-Related Asthma: What is the Link?

This session was chaired by Dr Deepa Rastogi on Sunday, September 10th 2023, at the European Respiratory Society (ERS) International Congress held at Milan, Italy.

Longitudinal Cohorts in Airway Disease. What have they Taught us About Personalised Treatment of our Everyday Patients?

This session was chaired by Drs Omar Usmani (UK) and Dr Apostolos Bossios (Sweden) on Sunday September 10th 2023 at the European Respiratory Society (ERS)

Real-World Experience of Mepolizumab In Severe Eosinophilic Asthma – Five-Year Outcomes

This paper was presented as a part of the session “Real-life studies in asthma: all the way to clinical remission “ by Dr Amy Nuttall

Clinical Remission Following Biologic Initiation in Severe Asthma: Results of the International Severe Asthma Registry (ISAR)

This paper was presented as a part of the session “Real-life studies in asthma: all the way to clinical remission “ by Dr Trung Tran

Addressing Asthma Management Gaps with A Respiratory Digital Ecosystem: A Preliminary Analysis

This paper was presented as a part of the session “Digital health interventions for chronic obstructive pulmonary disease and asthma “ by Dr Christopher Licskai